Industry is a white knight right now. Don’t throw it away
Editor’s Commentary: Industry’s positive moment will be fleeting if it doesn’t embed the new ways it is operating in for the long term
Biopharma is having a moment. All eyes are on drug, diagnostic and vaccine developers to get us out of this crisis and back to work. Now, companies -- individually and collectively -- must make good decisions, and avoid bad ones, to avoid a post-COVID backslide from savior to villain.
Not all heroes wear capes, goes the saying. Many are wearing white coats and lab goggles, these days. No one is talking about drug pricing. Everyone is talking about vaccines, therapies and diagnostics.
Science is the biggest news story of the day. Words like the R number, specificity and sensitivity, are tripping off the tongue. The public is engaged in the